OVID Research Revenue and Competitors
Estimated Revenue & Valuation
- OVID Research's estimated annual revenue is currently $3.7M per year.
- OVID Research's estimated revenue per employee is $155,000
Employee Data
- OVID Research has 24 Employees.
OVID Research's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Scientific Researcher | Reveal Email/Phone |
OVID Research Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is OVID Research?
Working on generating viable eggs from stem cells
keywords:N/A
N/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
OVID Research News
2022-04-19 - Long Covid Is Americas Forgotten Pandemic Problem
Senator Tim Kaine, who has symptoms of long Covid, introduced legislation in March to expand research and provide resources for medical...
2022-04-13 - Ovid Adds Support for Clinician Performance Improvement and Patient-Centered Communication With Astute Doctor
WALTHAM, Mass., April 13, 2022--(BUSINESS WIRE)--Wolters Kluwer, Health announced that its medical research platform, Ovid®,...
2022-04-06 - Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. ... For more information about these and other Ovid research programs,...
Other Companies in Berkeley
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.7M | 24 | -11% | N/A |
#2 | $3.8M | 24 | 4% | N/A |
#3 | $2.4M | 24 | 20% | N/A |
#4 | $3.7M | 24 | 4% | N/A |
#5 | $3.5M | 24 | 9% | N/A |